Drugs / AQUACOBALAMIN
AQUACOBALAMIN
also known as
Aquocobalamin · Aquocobalamin hydroxide · Aquocobalamine · Hydroxocobalamin hydrate · Hydroxocobalaminum hydrate · Vitamin B12B
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04150042 | Jan 2021 → Dec 2028 expected | BRCA1-related cancer predisposition, BRCA2-related cancer predisposition, Her2-receptor negative breast cancer, PALB2-related cancer predisposition +3 | General Oncology, Inc. | Recruiting | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AQUACOBALAMIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594615 ↗ |
| Known as | Aquocobalamin | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594615 ↗ |
| Known as | Aquocobalamin hydroxide | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594615 ↗ |
| Known as | Aquocobalamine | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594615 ↗ |
| Known as | Hydroxocobalamin hydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594615 ↗ |
| Known as | Hydroxocobalaminum hydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594615 ↗ |
| Known as | Vitamin B12B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04150042 ↗ |
| Route | Intravenous | “Intravenous vitamin B12b” NCT04150042 ↗ |